Published in BMC Cell Biol on December 05, 2013
Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation. Mol Cancer (2017) 1.39
The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females. BMC Cancer (2014) 0.83
Human Mesenchymal Stem Cells Retain Multilineage Differentiation Capacity Including Neural Marker Expression after Extended In Vitro Expansion. PLoS One (2015) 0.79
Expression of CD24 in Human Bone Marrow-Derived Mesenchymal Stromal Cells Is Regulated by TGFβ3 and Induces a Myofibroblast-Like Genotype. Stem Cells Int (2015) 0.79
The developmental basis of mesenchymal stem/stromal cells (MSCs). BMC Dev Biol (2015) 0.78
Are nestin-positive mesenchymal stromal cells a better source of cells for CNS repair? Neurochem Int (2016) 0.77
Research Advancements in Porcine Derived Mesenchymal Stem Cells. Curr Stem Cell Res Ther (2016) 0.75
Suppression of tumor-derived Semaphorin 7A and genetic ablation of host-derived Semaphorin 7A impairs tumor progression in a murine model of advanced breast carcinoma. Int J Oncol (2017) 0.75
Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy (2006) 37.55
Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng (2001) 20.65
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet (2008) 12.59
Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A (2000) 11.41
Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells (2006) 8.61
Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol (2001) 7.20
The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet (1970) 7.16
Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol (2010) 4.03
Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol (2006) 3.95
Mesenchymal stem cell-mediated functional tooth regeneration in swine. PLoS One (2006) 3.91
Pancreatic cancer stem cells. J Clin Oncol (2008) 3.21
Semaphorin 7A promotes axon outgrowth through integrins and MAPKs. Nature (2003) 2.87
Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone (1992) 2.39
Cancer stem cells from colorectal cancer-derived cell lines. Proc Natl Acad Sci U S A (2010) 2.22
Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells. Blood (2007) 1.70
CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells. Stem Cells (2009) 1.68
Expression of B7-H1 in breast cancer patients is strongly associated with high proliferative Ki-67-expressing tumor cells. Int J Cancer (2007) 1.53
Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation. J Leukoc Biol (1995) 1.53
CD40 expression by human fibroblasts. Clin Immunol Immunopathol (1995) 1.46
Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study. Transplantation (2013) 1.39
Semaphorin 7A is a negative regulator of T cell responses. Immunity (2006) 1.33
Neural differentiation potential of human bone marrow-derived mesenchymal stromal cells: misleading marker gene expression. BMC Neurosci (2009) 1.31
Fibroblasts share mesenchymal phenotypes with stem cells, but lack their differentiation and colony-forming potential. Biol Cell (2011) 1.31
Molecular classification of borderline ovarian tumors using hierarchical cluster analysis of protein expression profiles. Int J Cancer (2002) 1.30
CD24: from A to Z. Cell Mol Immunol (2010) 1.28
Chemokines and CD40 expression in human fibroblasts. Eur J Immunol (2000) 1.24
The origin of phenotypic heterogeneity in a clonal cell population in vitro. PLoS One (2007) 1.16
Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes. Am Surg (1999) 1.14
Epigenetic gene expression noise and phenotypic diversification of clonal cell populations. Differentiation (2007) 1.12
Expression and function of semaphorin 7A in bone cells. Biol Cell (2005) 1.10
Human nasal mucosa contains tissue-resident immunologically responsive mesenchymal stromal cells. Stem Cells Dev (2010) 1.02
Intestinal epithelial cell-derived semaphorin 7A negatively regulates development of colitis via αvβ1 integrin. J Immunol (2011) 1.02
Prospective isolation of human MSC. Best Pract Res Clin Haematol (2011) 1.00
Human fibroblasts share immunosuppressive properties with bone marrow mesenchymal stem cells. J Clin Immunol (2010) 0.96
Proteomics-based signature for human benign prostate hyperplasia and prostate adenocarcinoma. Int J Oncol (2011) 0.94
Nasal septum-derived multipotent progenitors: a potent source for stem cell-based regenerative medicine. Stem Cells Dev (2011) 0.94
A comprehensive characterization study of human bone marrow mscs with an emphasis on molecular and ultrastructural properties. J Cell Physiol (2011) 0.91
Semaphorin 7A promotes angiogenesis in an experimental corneal neovascularization model. Curr Eye Res (2011) 0.90
Co-culture of mesenchymal-like stromal cells derived from human foreskin permits long term propagation and differentiation of human embryonic stem cells. J Cell Biochem (2011) 0.85
Two-dimensional gel analysis of protein expression in ovarian tumors shows a low degree of intratumoral heterogeneity. Electrophoresis (1999) 0.84
Multi-potent progenitors in freshly isolated and cultured human mesenchymal stem cells: a comparison between adipose and dermal tissue. Cell Tissue Res (2011) 0.83
Characterization of olfactory stem cells. Cell Transplant (2011) 0.80
Sample preparation of human tumors prior to two-dimensional electrophoresis of proteins. Electrophoresis (1995) 0.79
Human olfactory mucosa multipotent mesenchymal stromal cells promote survival, proliferation, and differentiation of human hematopoietic cells. Stem Cells Dev (2012) 0.79
Enhancement of lytic activity of leukemic cells by CD8+ cytotoxic T lymphocytes generated against a WT1 peptide analogue. Leuk Lymphoma (2009) 1.47
Improved grading of breast adenocarcinomas based on genomic instability. Cancer Res (2004) 1.47
Breast carcinoma-associated fibroblasts and their counterparts display neoplastic-specific changes. Cancer Res (2008) 1.45
Role of the phosphoinositide 3-kinase p110delta in generation of type 2 cytokine responses and allergic airway inflammation. Eur J Immunol (2007) 1.23
Microvascular injury, thrombosis, inflammation, and apoptosis in the pathogenesis of heatstroke: a study in baboon model. Arterioscler Thromb Vasc Biol (2008) 1.13
Therapeutic targeting of B7-H1 in breast cancer. Expert Opin Ther Targets (2011) 1.12
Large-scale proteomics analysis of human ovarian cancer for biomarkers. J Proteome Res (2007) 1.12
Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules. PLoS One (2011) 1.10
Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule. Breast Cancer Res (2010) 1.03
Curcumin inhibits the Sonic Hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells. Mol Carcinog (2010) 1.01
Protein expression changes in ovarian cancer during the transition from benign to malignant. J Proteome Res (2012) 1.00
Profiling of normal and malignant breast tissue show CD44high/CD24low phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers. BMC Cancer (2013) 0.97
HLA-DRB1 among patients with Vogt-Koyanagi-Harada disease in Saudi Arabia. Mol Vis (2009) 0.94
Proteomics-based signature for human benign prostate hyperplasia and prostate adenocarcinoma. Int J Oncol (2011) 0.94
Optic gliomas: a retrospective analysis of 50 cases. Int J Radiat Oncol Biol Phys (2003) 0.92
The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy. Cancer Res (2008) 0.91
Regulation of phosphoinositide 3-kinase signaling by oxidants: hydrogen peroxide selectively enhances immunoreceptor-induced recruitment of phosphatidylinositol (3,4) bisphosphate-binding PH domain proteins. Cell Signal (2006) 0.91
Toll-like receptor 3 polymorphism and its association with hepatitis B virus infection in Saudi Arabian patients. J Med Virol (2012) 0.88
Phosphoinositide 3-kinase-regulated adapters in lymphocyte activation. Immunol Rev (2009) 0.86
Prevalence of PIK3CA mutations and the SNP rs17849079 in Arab breast cancer patients. Cancer Biol Ther (2013) 0.83
The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females. BMC Cancer (2014) 0.83
Camel urine components display anti-cancer properties in vitro. J Ethnopharmacol (2012) 0.82
Humoral and cellular immune responses to glucose regulated protein 78 -- a novel Leishmania donovani antigen. Trop Med Int Health (2002) 0.82
Repeated remissions of Cushing's disease due to recurrent infarctions of an ACTH-producing pituitary macroadenoma. Pituitary (2005) 0.80
The pleckstrin homology domain adaptor protein Bam32/DAPP1 is required for germinal center progression. J Immunol (2009) 0.80
Proteomic analysis of soft tissue tumor implants treated with a novel polybisphosphonate. Cancer Genomics Proteomics (2014) 0.80
A study of KIR genes and HLA-C in Vogt-Koyanagi-Harada disease in Saudi Arabia. Mol Vis (2011) 0.80
The cell cycle associated protein, HTm4, is expressed in differentiating cells of the hematopoietic and central nervous system in mice. J Mol Histol (2005) 0.79
A novel HAX1 gene mutation in severe congenital neutropenia (SCN) associated with neurological manifestations. Eur J Pediatr (2010) 0.79
Cancer stem cell immunotherapy: the right bullet for the right target. Hematol Oncol Stem Cell Ther (2010) 0.79
The selective cytotoxic anti-cancer properties and proteomic analysis of Trigonella Foenum-Graecum. BMC Complement Altern Med (2014) 0.79
Single nucleotide polymorphisms in CXCR1 gene and its association with hepatitis B infected patients in Saudi Arabia. Ann Hepatol (2013) 0.78
Serum efficacy biomarkers for oncology. Biomark Med (2009) 0.78
Development of a novel poly bisphosphonate conjugate for treatment of skeletal metastasis and osteoporosis. Int J Oncol (2010) 0.76
Comment on "Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells". J Immunol (2007) 0.75
del(6)(p23) in two cases of de novo AML--a new recurrent primary chromosome abnormality. Eur J Haematol (2006) 0.75
Granular cell meningioma. A case report. Folia Neuropathol (2007) 0.75
Severe hypertension secondary to renal artery stenosis and Cushing's syndrome. Saudi Med J (2005) 0.75
Bone marrow examination in staging of Lymphoma: Revisited. Saudi Med J (1998) 0.75